For full-year 2024, Elevance reported $175.2 billion in revenue, an increase of 2.9% over its $170.2 billion haul in 2023.

Elevance continues to expect its Medicare Advantage program to hit 2.2 million to 2.25 million members in 2025, and for adjusted earnings to be $34.15 to $34.85 a share.

Elevance Health (ELV) stock slips amid pressure from UnitedHealth's (UNH) Q1 results, even as its own early Q1 2025 results ...

Elevance Health said on Thursday it expects first-quarter profit above estimates, helped by medical cost trends that were in line with its expectations. The company forecast first-quarter adjusted ...

In a regulatory filing, Elevance Health (ELV) noted it will release its first quarter 2025 financial results on April 22. “First quarter ...

In a regulatory filing, Elevance Health (ELV) noted it will release its first quarter 2025 financial results on April 22. The company expects ...

Elevance Health Down Over 5%, On Pace For Largest Percent Decrease Since October 2024 — Data Talk Elevance Health, Inc. (ELV) is currently at $410.96, down $24.08 or 5.54% --Would be lowest close ...

Elevance Health on Thursday forecast a first-quarter profit above estimates and maintained its annual profit view, hours after industry bellwether UnitedHealth cut its outlook and sparked a selloff in ...

With a market cap of $102.5 billion, Elevance Health, Inc. (ELV) is a health benefits company offering a wide range of medical, pharmacy, and healthcare services across its four segments ...

Sustainalytics’ controversies research identifies companies involved in incidents and events that may negatively affect stakeholders, the environment or the company’s operations. Controversies are ...

The Step Ahead to Fall Prevention E-learning Module was updated in December 2024 by Toronto Public Health from the original version created in partnership with York Region Public Health. The ...